Psyence

About:

Psyence develops natural psilocybin products for the treatment of psychological trauma and mental health disorders

Website: https://psyence.com

Twitter/X: PsyenceGroup

Top Investors: Cantheon Capital, Brandon Kerzner

Description:

Psyence is a life science biotechnology company that has pioneered the use of natural psilocybin to heal psychological trauma and the diagnosable disorders that can result from it, including anxiety, depression, PTSD, stress, grief, and bereavement. It focuses on these diseases in the context of palliative care. The company conducts scientific research and development of psilocybin medical products for research institutions, clinics, and psilocybin-containing products that are regulatory-compliant. It is also working on functional mushroom nutraceutical products to treat depression, anxiety, and sleep disorders.